Transplantation of syngenic bone marrow contaminated with NCFr-marked WEHI-3B cells: An improved model of leukemia relapse in mice

Leukemia

Volumn 14, Issue 3, 2000, Pages 457-465

  Garcia Castro J ^a   Segovia, J C ^a   Bueren, J A ^a  

^a CIEMAT   (Spain)

Author keywords

Gene marking; Leukemia relapse; Mouse models; WEHI 3B cells

Indexed keywords

CELL MARKER; MYELOABLATIVE AGENT; NERVE GROWTH FACTOR RECEPTOR; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW PURGING; BONE MARROW TRANSPLANTATION; CANCER RECURRENCE; CELL GROWTH; CLONE; CONTAMINATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSDUCTION; LEUKEMIA; LEUKEMIA CELL; MOUSE; MYELOMONOCYTIC LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; SURVIVAL TIME; TRANSGENE;

EID: 0343067118     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401697     Document Type: Article

References (26)

1. Gorin NC. Autologous stem cell transplantation in acute myelocytic leukemia. Blood 1998; 92: 1073-1090.
2. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb H, Rimm AA, Ringdén O, Rozman C, Speck B, Truitt RL, Zwaan FE, Bortin MM. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555-562.
3. Brenner MK, Rill DR, Moen RC, Krance RA, Mirro JRJ, Anderson WF, Ihle JN. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 1993; 341: 85-86.
4. + murine cells as an in vivo model of acute nonlymphocytic leukemia. Exp Hematol 1989; 17: 130-137.
5. + murine leukemic cell line as an in vivo model of acute non-lymphocytic leukemia. Leukemia 1993; 7: 310-317.
6. Hendrikx PJ, Martens ACM, Schultz FW, Visser JWM, Hagenbeek A. Monitoring of leukemia growth in a rat model using a highly sensitive assay for the detection of LacZ marked leukemic cells. Leukemia 1995; 9: 1954-1960.
7. Yang Y, Martens ACM, de Groot CJ, Hendrikx PJ, Valerio DW, van Bekkum DW, Hagenbeek A. Retrovirus-mediated transfer and expression of marker genes in the BN rat acute myelocytic leukemia model for the study of minimal residual disease (MRD). Leukemia 1993; 7: 131-139.
8. Mavilio F, Ferrari G, Rossini S, Nobili N, Bonini C, Casorati G, Traversari C, Bordignon C. Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer. Blood 1994; 83: 1988-1997.
9. Fehse B, Li Z, Schade UM, Uhde A, Zander AR. Impact of a new generation of gene transfer marker on gene therapy. Gene Therapy 1998; 5: 429-430.
10. Machl AW, Planitzer SA, Kubbies M. I-NGFR receptor is a new flow cytometric tool for rapid cell cycle-correlated gene therapy complementation studies in viable cells. Cytometry 1997; 29: 371-374.
11. Phillip K, Gentry T, McCowage G, Gilboa E, Smith C. Cell-surface markers for assessing gene transfer into human hematopoietic cells. Nature Med 1996; 2: 1154-1156.
12. Warner NL, Moore MAS, Metcalf D. A transplantable myelomonocytic leukemia in BALB/c mice: cytology, karyotype, and muramidase content. J Natl Cancer Inst 1969; 43: 963-982.
13. Muench M, Guy Z, Moore M. Ex vivo differentiation therapy as a method of leukemic cell purging in murine bone marrow expansion cultures. Cancer Res 1992; 52: 6576-6582.
14. Fuji S, Hamada H, Fujimoto K, Shimomura T, Kawakita M. Activated dendritic cells from bone marrow cells of mice receiving cytokine-expressing tumor cells are associated with the enhanced survival of mice bearing syngeneic tumors. Blood 1999; 93: 4328-4335.
15. Nakazaki Y, Tani K, Lin Z, Sumimoto H, Hibino H, Tanabe T, Wu M, Izawa K, Hase H, Takahashi S, Tojo A, Azuma M, Hamada H, Mori S, Asano S. Vaccine effect of granulocyte-macrophage colony-stimulating factor or CD80 gene-transduced murine hematopoietic tumor tells and their cooperative enhancement of antitumor immunity. Gene Therapy 1998; 5: 1355-1362.
16. Cheng L, Du C, Lavau C, Chen S, Tong J, Chen BP, Scollay R, Hawley RG, Hill B. Sustained gene expression in retrovirally transduced, engrafting human hematopoietic stem cells and their lympho-myeloid progeny. Blood 1998; 92: 83-92.
17. Varas F, Bernad A, Bueren JA. Granulocyte colony-stimulating factor mobilizes into peripheral blood the complete clonal repertoire of hematopoietic precursors residing in the bone marrow of mice. Blood 1996; 88: 2495-2501.
18. Bonini C, Ferrari G, Verzeletti S, Servida P, Zappone E, Ruggieri L, Ponzoni M, Rosini S, Mavilio F, Traversari C, Bordignon C. HSV-TK Gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 1997; 276: 1719-1724.
19. Laird PW, Zijderveld A, Linders K, Rudnicki MA, Jaenisch R, Berns A. Simplified mammalian DNA isolation procedure. Nucleic Acids Res 1991; 19: 4293.
20. Maniatis T, Fritsch EF, Sambrook J (eds). Molecular Cloning: a Laboratory Manual. Cold Spring Harbor Laboratory: New York, 1982.
21. Bernad A, Varas F, Gallego JM, Almendral JM, Bueren JA. Ex vivo expansion and selection of retrovirally transduced bone marrow: and efficient methodology for gene-transfer to murine lymphohaemopoietic stem cells. Br J Haematol 1994; 87: 6-17.
22. Deisseroth AB, Zu Z, CLaxton D, Hanania EG, Fu S, Ellerson D, Goldberg L, Thomas M, Janicek K, Anderson WF. Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 1994; 83: 3068-3076.
23. Robinet E, Certoux JM, Ferrand C, Maples P, Hardwick A, Cahn JY, Reynolds CW, Jacob W, Herve P, Tiberghien P. A closed culture system for the ex vivo transduction and expansion of human T lymphocytes. J Hematother 1998; 7: 205-215.
24. Ymer S, Tucker WQ, Sanderson CJ, Hapel AJ, Campbell HD, Young IG. Constitutive synthesis of interleukin-3 by leukaemia cell line WEHI-3B is due to retroviral insertion near the gene. Nature 1985; 317: 255-258.
25. Güenechea G. Radioprotección conferida por polisacáridos iónicos en ratón. Relación con su capacidad para estimular el sistema hematopoyético. PhD Thesis, Universidad Complutense de Madrid, 1995.
26. Fung M, Szeto Y, Leung K, Wong-Leung Y, Mak N. Effects of biochain A on the growth and differentiation of myeloid leukemia WEHI-3B (JCS) cells. Life Sci 1997; 61: 105-115.